Cabahug, Melogie .
HRN: 03-07-41 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2023
CO-AMOXICLAV 625MG (TAB)
12/29/2023
01/05/2024
PO
500
BID
3rd Degree RMLE
Waiting Final Action
Indication: Prophylaxis Type of Infection: Prophylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes